Prevention of Subsequent L-Asparaginase Hypersensitivity in Children Through Premedication: A Single-Center Experience.
In resource-limited settings, our premedication protocol demonstrated potential for safely enabling continued native <i>E. coli</i> L-asparaginase therapy in children with a history of severe hypersensitivity reactions, thus potentially improving access to chemotherapy treatment.
Authors
- Lalita Sathitsamitphong (ORCID: https://orcid.org/0000-0003-4774-259X)
- Mongkol Lao-Araya
- Chane Choed-Amphai
- Pongsathorn Saligupta
Institutions
- Chiang Mai University (TH)
Publication Details
- Journal
- PubMed
- Published
- 2026-02-01
- DOI
- https://doi.org/10.5863/jppt-25-00031
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 0.00